Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Statement re Offer for Subscription

10 Jan 2022 12:43

RNS Number : 9606X
Maven Income and Growth VCT 3 PLC
10 January 2022
 

Maven Income and Growth VCT 3 PLC and Maven Income and Growth VCT 4 PLC (the Companies)

 

Offers for Subscription - Early Investment Incentive

 

10 January 2022

 

On 20 September 2021, the Companies published a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription of new Ordinary Shares of 10p each (together the "Offers" and each an "Offer").

 

In the Prospectus, it was stated that all valid applications that were received (together with their relevant application monies) by the deadline of 12.00 noon on 28 January 2022 would be eligible to receive an Early Investment Incentive discount under the Offers. Existing Shareholders (and their spouses or partners) in any of the Maven VCTs, including the Companies, at the time the application was received would benefit from an enhanced rate of discount in recognition of their continued support for the Maven VCTs. The levels of discount to be applied would be:

 

· 1.5% of the application amount for Existing Shareholders; and

· 1.25% of the application amount for New Investors.

 

It was also stated that each Company could, in consultation with Maven Capital Partners UK LLP (Maven) and in their absolute discretion, extend the deadline by which applications must be received to be eligible for the Early Investment Incentive under its Offer.

 

The Board of each Company confirms that the deadline by which applications must be received to be eligible for the Early Investment Incentive under their Company's respective Offer has been extended until close of business on Wednesday 2 February 2022. Furthermore, it is anticipated that both Companies will make initial allotments of new Ordinary Shares under their respective Offers as soon as practicable after that date.

 

Further information

 

Any enquiries in respect of the Offers, or requests for copies of the Prospectus documents (available free of charge), should be directed to:

 

Maven Capital Partners UK LLP

Kintyre House

205 West George Street

Glasgow

G2 2LW

 

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Downloadable versions of the Prospectus documents are available from the Maven website at: www.mavencp.com/vctoffer.

Maven Capital Partners UK LLPSecretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFLFSFLIIILIF
Date   Source Headline
13th Feb 201312:11 pmRNSMerger Update
9th Nov 20125:01 pmRNSInterim Management Statement
31st Oct 20125:03 pmRNSHalf Yearly Report
31st Oct 20124:25 pmRNSDoc re. Joint Announcement of Potential Merger
31st Oct 20124:25 pmRNSDoc re. Joint Announcement of Potential Merger
28th Aug 20125:24 pmRNSHalf Yearly Report
12th Jul 20125:01 pmRNSAnnual Information Update
17th May 20121:02 pmRNSResult of AGM
17th May 20129:31 amRNSInterim Management Statement
3rd May 20125:36 pmRNSTransaction in Own Shares
2nd May 20124:12 pmRNSDirector/PDMR Shareholding
2nd May 20123:59 pmRNSDirector/PDMR Shareholding
2nd May 20123:30 pmRNSTransaction in Own Shares
26th Apr 20122:24 pmRNSTransaction in Own Shares
20th Apr 20121:11 pmRNSIssue of Equity
18th Apr 201212:26 pmRNSAnnual Financial Report - Replacement
17th Apr 20124:40 pmRNSAnnual Financial Report
10th Apr 20129:59 amRNSIssue of Equity
8th Mar 20124:02 pmRNSDirector/PDMR Shareholding
2nd Mar 20129:39 amRNSIssue of Equity
7th Dec 20114:20 pmRNSIssue of Equity
22nd Nov 20114:45 pmRNSTransaction in Own Shares
17th Nov 20114:55 pmRNSTransaction in Own Shares
16th Nov 20113:09 pmRNSInterim Management Statement
29th Sep 20115:04 pmRNSTransaction in Own Shares
15th Aug 20113:34 pmRNSHalf Yearly Report
1st Jul 20117:00 amRNSTransaction in Own Shares
29th Jun 20112:44 pmRNSTransaction in Own Shares
29th Jun 20112:43 pmRNSTransaction in Own Shares
14th Jun 201110:51 amRNSStatement re cancellation of share premium
24th May 20113:27 pmRNSAnnual Information Update
20th May 20114:16 pmRNSInterim Management Statement
12th May 201111:08 amRNSResult of AGM
4th May 20113:26 pmRNSIssue of Equity
14th Apr 20116:09 pmRNSDirector/PDMR Shareholding
6th Apr 20119:33 amRNSIssue of Equity
14th Mar 20115:26 pmRNSAnnual Financial Report
2nd Mar 20119:58 amRNSTotal Voting Rights
2nd Feb 20114:14 pmRNSIssue of Equity
1st Feb 20112:31 pmRNSResult of EGM
7th Jan 20114:52 pmRNSCirc re. cancellation of share premium account
26th Nov 20103:51 pmRNSDirector/PDMR Shareholding
24th Nov 20103:39 pmRNSTransaction in Own Shares
19th Nov 201010:32 amRNSInterim Management Statement
18th Nov 20102:03 pmRNSStatement re Linked Offer for Subscription
16th Aug 20104:45 pmRNSInterim Results
29th Jun 20103:36 pmRNSTransaction in Own Shares
28th May 20105:16 pmRNSTransaction in Own Shares
20th May 20104:49 pmRNSInterim Management Statement replacement
20th May 20109:07 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.